Board Member*
- Serial founder-CEO to six biotechs – all successfully sold.
- Incro (to Denali ), Covella, Conforma, Cabrellis, Athena, Auspex (to Teva for $2B).
- PhD (Biophysics) Rockefeller University.
*Board tenure to start in Q1 of 2019; advisory to Board in interim term.
